Table 2 Pearson's coefficient of LDL particle size with lipid profile and atherogenic rates in our population
From: Observational study of lipid profile and LDL particle size in patients with metabolic syndrome
LDL particle size | Without MS (N = 72) | With MS (N = 113) | ||
|---|---|---|---|---|
r | p -value | r | p -value | |
Plasma cholesterol (mg/dL) | -0.38 | 0.001* | -0.02 | 0.859 |
Plasma triglycerides (mg/dL) | -0.69 | > 0.001* | -0.19 | 0.041* |
LDL cholesterol (mg/dL) | -0.31 | 0.008* | 0.07 | 0.472 |
HDL cholesterol (mg/dL) | 0.28 | 0.019* | 0.05 | 0.631 |
Apo A-I (mg/dL) | 0.03 | 0.833 | 0.14 | 0.173 |
Apo A-II (mg/dL) | -0.22 | 0.071 | 0.01 | 0.893 |
Apo B (mg/dL) | -0.40 | 0.001* | -0.38 | > 0.001* |
Lipoprotein (a) (mg/dL) | 0.07 | 0.561 | 0.02 | 0.851 |
Apo B/Apo A-I ratio | -0.37 | 0.002* | -0.37 | > 0.001* |
Plasma cholesterol/HDL-c ratio | -0.50 | > 0.001* | -0.09 | 0.343 |
Plasma triglycerides/HDL-c ratio | -0.67 | > 0.001* | -0.18 | 0.068 |
Log (TG/HDL-c) ratio | -0.59 | > 0.001* | -0.18 | 0.056 |